GlassScriptPhysician profile
Harrison K Rhee
NPI 1659319762
$2,503.93
in general payments reported to CMS, 2019-2025
26 companies · $28.18 in 2025
The $28.18 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $137 · 2021: $131 · 2022: $476 · 2023: $876 · 2024: $573 · 2025: $28.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,476.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $275.47 | 2022-2023 | Aquabeam Robotic System |
| Dendreon Pharmaceuticals LLC | $265.35 | 2023-2024 | Provenge |
| Coloplast Corp | $261.42 | 2019-2024 | Speedicath, Titan |
| Sumitomo Pharma America, INC. | $189.86 | 2023-2024 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $181.81 | 2019-2024 | Myrbetriq |
| Medtronic, INC. | $177.41 | 2022-2023 | Interstim |
| C. R. Bard, INC. & Subsidiaries | $167.27 | 2023-2025 | Bard Urinary Drainage Bag |
| Abbvie INC. | $126.99 | 2019-2024 | |
| Olympus America INC. | $122.08 | 2023-2024 | Itind System |
| Boston Scientific Corporation | $92.97 | 2019-2023 | Greenlight Xps |
| Neotract INC. | $90.13 | 2020 | |
| Urogen Pharma, INC. | $76.83 | 2021-2024 | |
| Pfizer INC. | $66.94 | 2019-2022 | |
| Teleflex LLC | $63.87 | 2022-2023 | Urolift |
| Rochester Medical Corporation | $46.42 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $45.21 | 2019-2024 | Aveed, Xiaflex |
| Urovant Sciences INC | $40.98 | 2022 | |
| Ferring Pharmaceuticals INC. | $34.47 | 2024 | Adstiladrin |
| Mission Pharmacal Company | $31.31 | 2020-2022 | |
| Abc Home Medical Supply, INC. | $25.24 | 2022 | |
| Ambu INC. | $24.86 | 2024 | |
| Antares Pharma, INC. | $23.83 | 2022 | |
| Progenics Pharmaceuticals, INC. | $20.77 | 2024 | |
| Axonics, INC. | $19.53 | 2023 | Axonics |
| Medtronic USA, INC. | $17.28 | 2020 | |
| Kerecis Limited | $15.63 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harrison Rhee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.